Anthracycline, gemcitabine, and pazopanib in epithelioid sarcoma a multi-institutional case series

A.M. Frezza, R.L. Jones, S.L. Vullo, N. Asano, F. Lucibello, E. Ben-Ami, R. Ratan, P. Teterycz, K. Boye, M. Brahmi, E. Palmerini, A. Fedenko, B. Vincenzi, A. Brunello, I.M.E. Desar, R.S. Benjamin, J.Y. Blay, J.M. Broto, P.G. Casali, H. GelderblomG. Grignani, A. Gronchi, K.S. Hall, O. Mir, P. Rutkowski, A.J. Wagner, O. Anurova, P. Collini, A.P.D. Tos, U. Flucke, J.L. Hornick, I. Lobmaier, T. Philippe, P. Picci, D. Ranchere, S.L. Renne, M. Sbaraglia, K. Thway, M. Wagrodzki, W.-L. Wang, A. Yoshida, L. Mariani, A. Kawai, S. Stacchiotti

Research output: Contribution to journalArticle

Original languageUndefined/Unknown
JournalJAMA oncology
Volume4
Issue number9
DOIs
Publication statusPublished - 2018

Cite this

Frezza, A. M., Jones, R. L., Vullo, S. L., Asano, N., Lucibello, F., Ben-Ami, E., Ratan, R., Teterycz, P., Boye, K., Brahmi, M., Palmerini, E., Fedenko, A., Vincenzi, B., Brunello, A., Desar, I. M. E., Benjamin, R. S., Blay, J. Y., Broto, J. M., Casali, P. G., ... Stacchiotti, S. (2018). Anthracycline, gemcitabine, and pazopanib in epithelioid sarcoma a multi-institutional case series. JAMA oncology, 4(9). https://doi.org/10.1001/jamaoncol.2018.0219